Blood Group Typing Market Size to Record 9.1% CAGR Over 2023-2030; Rise in Number of Blood Donations to Augment Market Growth

The global blood group typing market size stood at USD 1.80 billion in 2022 and is predicted to touch USD 1.96 billion in 2023. The market is estimated to reach USD 3.60 billion by 2030, recording a CAGR of 9.1% during 2023-2030.

Fortune Business Insights™ presents this information in its report titled, “Blood Group Typing Market Size, Share & COVID-19 Impact Analysis, By Product (Instruments and Reagents & Kits), By Test Type (ABO Tests, Antigen Typing, Antibody Screening, Cross-Matching Tests, and HLA Typing), By Technique (Serology Tests and Molecular Tests), By End-user (Hospital-based Laboratories and Independent Laboratories & Blood Banks), and Regional Forecast, 2023-2030”.

The demand for blood transfusions and donations is growing at a considerable rate across the globe due to the rising incidence of accidents and trauma injuries. This factor has also fueled the need for blood group typing techniques to cater to the growing number of blood transfusions.

Market Growth Impacted Due to Decline in Hospital Visits amid COVID-19 Pandemic

The COVID-19 crisis resulted in a notable decline in the number of blood transfusions and donations. This had a considerable impact on the industry expansion. This period further registered a reduction in the number of patient visits to healthcare units along with considerable disruptions in manufacturing and supply chains. However, the industry is anticipated to record a revival in product demand considering the robust adoption of automated technologies.

Rise in Number of Blood Donations to Augment Market Growth

There has been a commendable rise in the number of blood donations across the world due to rising incidence of road accidents and chronic diseases. The demand for blood group recognition and cross-matching techniques for transfusions has grown due to the increasing number of voluntary blood donations. The need for blood and blood components has also gone up in recent years to cater to the medical needs of many surgical and medical applications. Moreover, governments across the world have introduced various initiatives to boost awareness regarding blood transfusions and donations, thereby fueling the blood group typing market growth.

To get a detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/industry-reports/blood-group-typing-market-101767

Competitive Landscape

QuidelOrtho Corporation Dominated Market with Robust Product Portfolio

The market is showing notable growth due to the presence of reputed companies that are constantly innovating their product ranges to gain a strong foothold in the market. However, QuidelOrtho Corporation held a dominant position in the market in 2022 as the company is taking various efforts to secure approvals for their newly launched products. QuidelOrtho is also entering a wide range of long-term distribution agreements, thereby helping it secure a leading position in the market and expand its customer base.

Notable Industry Development:

• February 2022: INTECH announced the availability of a newly redesigned ABO & RhD Blood Grouping Kit (solid-phase method) to carry out blood typing and screening processes.

List of Key Players Profiled in the Report:

• Quotient Limited (Switzerland)


• CareDx Inc. (U.S.)


• Agena Bioscience, Inc. (Mesa Laboratories, Inc.) (U.S.)


• DIAGAST (U.S.)


• Illumina, Inc. (U.S.)


• Grifols, S.A. (Spain)


• Immucor, Inc. (U.S.)


• Bio-Rad Laboratories, Inc. (U.S.)


• Thermo Fisher Scientific Inc. (U.S.)


• Merck KGaA (Germany)


• QIAGEN (Netherlands)


• Beckman Coulter, Inc. (Danaher) (U.S.)


• QuidelOrtho Corporation (U.S.)

Further Report Findings

• North America is expected to record a substantial growth rate in the global market during the forecast period. The regional market’s strong growth can be credited to the increasing regulatory approvals for the rollout and deployment of advanced products and rising number of blood transfusions.


• The Asia Pacific blood group typing market share is expected to grow at a commendable pace during the forecast period. The regional market’s growth can be attributed to the rising number of R&D initiatives to introduce innovative blood group typing technologies.


• The serology tests segment is anticipated to record commendable growth rate throughout the estimated period. The segment’s notable growth is being driven by increasing initiatives for voluntary blood donations and launch of new products to enhance the performance of these tests.

Table of Segmentation